Netherlands Heart Journal: just a change of name or more?
:94A50ksr ,.,+M .lophes
J.GAM. Crlns Grntgen Roterjam PJ.dS* I;y den :: M.; qrs Li_wn '.H van|Xt:: Groningen Utroect R.N.W. Haiuer Ubet: ' *M van 'm. m:k >tLH. .t- :: t JW. JJukem j.;P. :';
You have before you the very first edition of the Netherlands Heart Journal. You may wonder whether this is a new journal or just a change of name, and why this is necessary anyway? In our opinion, it is both and it is necessary. On one hand, the Netherlands Heart Journal will offer something quite new, and on the other hand, it will be a logical sequence to what has already been established with our former journal entitled Cardiologie. To start with the things that will be preserved: the Editorial Board will remain largely the same, the lay-out will undergo only minor changes, and the Journal will continue to act as the mouthpiece of our Netherlands Society of Cardiology and the Netherlands Heart Foundation. It will still be published by Mediselect bv. In addition, the news section from the National Society (yellow pages) will continue to appear in Dutch, as well as the news from the Netherlands Heart Foundation and the Cardiovascular Educational Institute (CVOI). So what's new? As of this issue, all articles editorials, review articles, original articles, case histories, or contributions to the imaging section will be published exclusively in the English language. Does this justify a name change? Cardiologie is clearly a Dutch title. It was given to the journal because in 1994 when it was founded articles were accepted in both Dutch and English. The current complete transition to the English language warranted an English title and all three bodies (National Society of Cardiology, Netherlands Heart Foundation, Mediselect bv) have consented to the title Netherlands Heart Journal. What are the implications? As was announced during the autumn 2000 meeting of our National Society (28 October, Amsterdam), the Chief Editorial Board felt that we should aim for a more prestigious journal in view of the fact that the scientific level and publication rate of the Netherlands is well acknowledged worldwide. This holds in particular for the field of cardiovascular medicine where the Netherlands invariably reaches very high production and citation scores. As a result, the Netherlands deserves a journal that is recognised both nationally and internationally. There are a number of outstanding scientists in cardiovascular medicine in the Netherlands who have given our country an excellent reputation and great fame. What will be our primary aim? By improving the scientific level of our journal, we plan in the first instance to work towards indexing by Index medicus. This generally improves the status of a journal and it shows its international acceptance and acknowledgement. Our primary goal is not to compete with major international cardiology journals that are impactfactor driven, but indexing per se and the subsequent citation on PubMed (or similar institutions) is a major aim to strive for at the moment. How to fillfil these aims? One of the most important new focus points of the journal will be the acquisition of original articles. This is vital to any journal, but usually a difficult task for a journal that has not (yet) been indexed. Fortunately, we can envisage three potential sources of original articles. First, we have an editorial board consisting of eminent clinicians -
.......van r Learn
H~. MI. s
:A xOP t
JJJtC. Riiii'slm WJ. Remme *.AC..va
Rot~evdam Amst. 'wetct'
M0L Simon W.A.. V. .h
oI HCt ZwoitS
' " '
Netherlands Heart Joumal, Volume 9, Number 1, April 2001
PO BOx 63,3830 AS Leusden, The
Tel.: +3133422 99 00 Fax: +31-33422 99 22
ISSN 156885888 Netherlands Heart
Journal -is publshed Meselt t
Socit of C
Itemsts and peadeai
TheEditoria sBoard is The onons eprehd bymthe Ediorel and fth oar ce
the CVOI section
responsilblty ofttal E*dr. 2SOOcopies.'
ntilt the id Of
stored in tMomaybe. repr TedOrferv.r ,Wwht voor. WHfd in ainy or-by 3
recordfngor sion, -in
The: Edioril Board and Publisr will resposible for-th publshe
artices' of the
an authors name or
and cardiovascular scientists. Several ofthe editorial board members have an impressive publication record, some with over 100 citations on PubMed. One of our board members, Prof. Dr. Patrick Serruys, even has the highest citation score worldwide! In view of the publication drive ofmany board members, we would ask these individuals to report initial findings in our Journal and to stimulate their co-workers to do so too. Second, other sources of original articles are those that are part of a PhD thesis. In the Netherlands, a thesis usually consists of a composition of original articles around one major theme (at least four, but commonly five or more, 'unwritten rule'). At the time ofthe appearance of the thesis, not all ofthese articles will have been published, and it is rather disappointing to learn that some of them keep the label 'submitted' forever. In our view, many ofthose articles merit publication in the 'new' Netherlands Heart Journal. It should be the task of the Department Chiefs to convince young PhD doctors to consider submitting their work to our Journal. Lastly, as our doctors-in-training for cardiology are united in what we call the Junior Chamber, we appeal to them to report their initial research in our Journal. To this purpose, a member of the Junior Chamber (Dr. Joost Kruik) has gained a permanent position on the Editorial Board. So, there is every reason to believe that this impetus might upgrade the Journal to a successful standard. Naturally, we would also welcome interesting articles from outside the Netherlands, as this will contribute to the standing of the Journal. With the appearance ofthe first issue of the Netherlands Heart Journal, some changes in the Editorial Board have to be mentioned. First, Dr. Nicole Panhuyzen-Goedkoop will leave the Chief Editorial Board after having reached her six-year term. We gratefully acknowledge the efforts of Nicole Panhuyzen-Goedkoop over the past six years. She was primarily responsible for the 'University News' and 'Summaries of PhD Theses' sections. Nicole Panhuyzen will stay in the Editorial Board as coordinator of the Netherlands Institute for Continuing Cardiovascular Education (CVOI). She will be replaced by Dr. Pieter Doevendans (Maastricht) who, apart from his expert knowledge in molecular cardiology, will be primarily responsible for retrieving original articles. Next, we have to say farewell to Prof. Dr. Herre Kingma, who has been appointed Inspector General of Health Care in our country. We thank him very much for his activities for our Journal and we wish him all the best in his new challenge. A new welcome to Prof. Wiek van Gilst, who will replace Prof. Kingma in the field of cardiovascular pharmacology, and to Dr. Rob de Wimter, who will be active in the domain of acute coronary syndromes. As indicated before, we expect a great deal from our Editorial Board members, as we need their active input. Finally, we hope that you really appreciate our efforts to make the Netherlands Heart Journal a new platform for cardiovascular research in a broadest sense of the word. We would be very pleased to hear your comments and criticism as this can only lead to improvement of our Journal! U On behalf of the ChiefEditorial Board, Ernst E. van der Wall.
fsele"ct bv Netherlands Heart Joumal, Volume 9, Number 1, April 2001